Triple
T4850372
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer |
E108398
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object |
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
|
E474928
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Array BioPharma | Statement: [Pfizer, hasSubsidiary, Array BioPharma]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Array BioPharma Context triple: [Pfizer, hasSubsidiary, Array BioPharma]
-
A.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Elan Pharmaceuticals
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
D.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Array BioPharma Triple: [Pfizer, hasSubsidiary, Array BioPharma]
Generated description
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Array BioPharma Target entity description: Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
-
A.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Elan Pharmaceuticals
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
D.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd440a89548190a5f14ba6da6b97dc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd6d1e5cf08190bd6b6a524748f170 |
completed | March 20, 2026, 3:51 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69be5cdefda8819095fbc04446bf32f5 |
completed | March 21, 2026, 8:54 a.m. |
| NEDg | Description generation | batch_69be5dadcec88190bf9a272c4a9aef9a |
completed | March 21, 2026, 8:58 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69be6159ff7c8190baa116240f76dea5 |
completed | March 21, 2026, 9:14 a.m. |
Created at: March 20, 2026, 1:25 p.m.